Aurobindo Pharma shares rise 2% on USFDA nod for nasal spray
The pharma company has received approval to manufacture and market Mometasone Furoate Monohydrate Nasal Spray 50 mcg, which will be launched in Q1 FY25.
aurobindo pharma shares
March 2024
December 2023
From ₹397 to ₹1,081: This largecap pharma stock surges 170% in 10 months
The homegrown pharma company has outperformed the BSE Sensex and Healthcare index in terms of returns in the last one year.
